Recent advances in liposome-based nanoparticles for antigen delivery

Polymer Reviews

Volumn 47, Issue 3, 2007, Pages 329-344

  Yan, Weili ^a   Huang, Leaf ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Adjuvant activity; Antigen delivery; Liposome; Nanoparticles; Target delivery

Indexed keywords

ADJUVANT ACTIVITY; ANTIGEN DELIVERY; IMMUNE RESPONSES; TARGET DELIVERY;

ANTIGENS; DNA; DRUG DELIVERY; LIPOSOMES; PEPTIDES; VACCINES;

NANOPARTICLES;

EID: 34547800749     PISSN: 15583724     EISSN: 15583716     Source Type: Journal    
DOI: 10.1080/15583720701455020     Document Type: Article

References (48)

1. Allison, A. G.; Gregoriadis, G. "Liposomes as immunological adjuvants", Nature 1974, 252, 252.
2. Uemura, A.; Watarai, S.; Iwasaki, T.; Kodama, H. "Induction of immune responses against glycosphingolipid antigens: comparison of antibody responses in mice immunized with antigen associated with liposomes prepared from various phospholipids", J. Vet. Med. Sci. 2005, 67, 1197-1201.
3. Gao, X.; Huang, L. "Potentiation of cationic liposome-mediated gene delivery by polycations", Biochemistry 1996, 35, 1027-1036.
4. Li, S.; Rizzo, M. A.; Bhattacharya, S.; Huang, L. "Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery", Gene Ther. 1998, 5, 930-937.
5. Dileo, J.; Banerjee, R.; Whitmore, M.; Nayak, J. V.; Falo, L. D., Jr.; Huang, L. "Lipid-protamine - DNA- mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses", Mol. Ther. 2003, 7, 640-648.
6. Li, B.; Li, S.; Tan, Y.; Stolz, D. B.; Watkins, S. C.; Block, L. H.; Huang, L. "Lyophilization of cationic lipid-protamine-DNA (LPD) complexes", J. Pharm. Sci. 2000, 89, 355-364.
7. Whitmore, M.; Li, S.; Huang, L. "LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth", Gene Ther. 1999, 6, 1867-1875.
8. Whitmore, M. M.; Li, S.; Falo, L., Jr.; Huang, L. "Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses", Cancer Immunol. Immunother. 2001, 50, 503-514.
9. Cui, Z.; Huang, L. "Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer", Cancer Immunol. Immunother. 2005, 54, 1180-1190.
10. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, C. A., Jr. "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature. 1997, 388, 394-397.
11. Rock, F. L.; Hardiman, G.; Timans, J. C.; Kastelein, R. A.; Bazan, J. F. "A family of human receptors structurally related to Drosophila Toll", Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 588-593.
12. Akira, S.; Uematsu, S.; Takeuchi, O. "Pathogen recognition and innate immunity", Cell. 2006, 124, 783-801.
13. Jiang, Z. H.; Bach, M. V.; Budzynski, W. A.; Krantz, M. J.; Koganty, R. R.; Longenecker, B. M. "Lipid A structures containing novel lipid moieties: synthesis and adjuvant properties", Bioorg. Med. Chem. Lett. 2002, 12, 2193-2196.
14. O'Neill, L. A. "How Toll-like receptors signal: what we know and what we don't know", Curr. Opin. Immunol. 2006, 18, 3-9.
15. Hoebe, K.; Janssen, E. M.; Kim, S. O.; Alexopoulou, L.; Flavell, R. A.; Han, J.; Beutler, B. "Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways", Nat. Immunol. 2003, 4, 1223-1229.
16. Yamamoto, M.; Sato, S.; Hemmi, H.; Hoshino, K.; Kaisho, T.; Sanjo, H.; Takeuchi, O.; Sugiyama, M.; Okabe, M.; Takeda, K.; Akira, S. "Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway", Science 2003, 301, 640-643.
17. Krieg, A. M. "CpG motifs in bacterial DNA and their immune effects", Annu. Rev. Immunol. 2002, 20, 709-760.
18. Li, S.; Wu, S. P.; Whitmore, M.; Loeffert, E. J.; Wang, L.; Watkins, S. C.; Pitt, B. R.; Huang, L. "Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors", Am. J. Physiol. 1999, 276, L796-804.
19. Hornung, V.; Guenthner-Biller, M.; Bourquin, C.; Ablasser, A.; Schlee, M.; Uematsu, S.; Noronha, A.; Manoharan, M.; Akira, S.; de Fougerolles, A.; Endres, S.; Hartmann, G. "Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7", Nat. Med. 2005, 11, 263-270.
20. Cui, Z.; Han, S. J.; Vangasseri, D. P.; Huang, L. "Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier", Mol. Pharm. 2005, 2, 22-28.
21. Vangasseri, D. P.; Cui, Z.; Chen, W.; Hokey, D. A.; Falo, L. D.; Huang, L. "Immunostimulation of dendritic cells by cationic liposomes", Mol. Membrane Biol. 2006,23, 1-11.
22. Harnett, W.; Deehan, M. R.; Houston, K. M.; Harnett, M. M. "Immunomodulatory properties of a phosphorylcholine-containing secreted filarial glycoprotein", Parasite Immunol. 1999, 21, 601-608.
23. Allaoui-Attarki, K.; Pecquet, S.; Fattal, E.; Trolle, S.; Chachaty, E.; Couvreur, P.; Andremont, A. "Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres", Infect. Immun. 1997, 65, 853-857.
24. Bakker-Woudenberg, I. A. "Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci", Int. J. Antimicrob. Agents 2002, 19, 299-311.
25. Yan, X.; Scherphof, G. L.; Kamps, J. A. "Liposome opsonization", J. Liposome Res. 2005, 15, 109-139.
26. Oussoren, C.; Storm, G. "Liposomes to target the lymphatics by subcutaneous administration", Adv. Drug Deliv. Rev. 2001, 50, 143-156.
27. Abra, R. M.; Hunt, C. A. "Liposome disposition in vivo. III. Dose and vesicle-size effects", Biochim. Biophys. Acta. 1981, 666, 493-503.
28. Litzinger, D. C.; Buiting, A. M.; van Rooijen, N.; Huang, L. "Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes", Biochim. Biophys. Acta. 1994, 1190, 99-107.
29. Moghimi, S. M. "The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes", Biomaterials 2006, 27, 136-144.
30. van Broekhoven, C. L.; Parish, C. R.; Demangel, C.; Britton, W. J.; Altin, J. G. "Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy", Cancer Res. 2004, 64, 4357-4365.
31. Mauk, M. R.; Gamble, R. C.; Baldeschwieler, J. D. "Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice", Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 4430-4434.
32. Cui, Z.; Han, S. J.; Huang, L. "Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor", Pharm. Res. 2004, 21, 1018-1025.
33. Mandal, M.; Kawamura, K. S.; Wherry, E. J.; Ahmed, R.; Lee, K. D. "Cytosolic delivery of viral nucleoprotein by listeriolysin O-liposome induces enhanced specific cytotoxic T lymphocyte response and protective immunity", Mol. Pharm. 2004, 1, 2-8.
34. Lee, K. D.; Oh, Y. K.; Portnoy, D. A.; Swanson, J. A. "Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes", J. Biol. Chem. 1996, 271, 7249-7252.
35. Stier, E. M.; Mandai, M.; Lee, K. D. "Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells", Mol. Pharm. 2005, 2, 74-82.
36. Mastrobattista, E.; Crommelin, D. J.; Wilschut, J.; Storm, G. "Targeted liposomes for delivery of protein-based drugs into the cytoplasm of tumor cells", J. Liposome Res. 2002, 12, 57-65.
37. Mastrobattista, E.; Koning, G. A.; van Bloois, L.; Filipe, A. C.; Jiskoot, W.; Storm, G. "Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins", J. Biol. Chem. 2002, 277, 27135-27143.
38. Schutze-Redelmeier, M. P.; Gournier, H.; Garcia-Pons, F.; Moussa, M.; Joliot, A. H.; Volovitch, M.; Prochiantz, A.; Lemonnier, F. A. "Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo", J. Immunol. 1996, 157, 650-655.
39. Chikh, G. G.; Kong, S.; Bally, M. B.; Meunier, J. C.; Schutze-Redelmeier, M. P. "Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells", J. Immunol. 2001, 167, 6462-6470.
40. Owais, M.; Gupta, C. M. "Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development", Eur. J. Biochem. 2000, 267, 3946-3956.
41. Kloetzel, P. M. "Antigen processing by the proteasome", Nat. Rev. Mol. Cell Biol. 2001, 2, 179-187.
42. Weissman, A. M. "Themes and variations on ubiquitylation", Nat. Rev. Mol. Cell Biol. 2001, 2, 169-178.
43. Chung, C. H.; Baek, S. H. "Deubiquitinating enzymes: their diversity and emerging roles", Biochem. Biophys. Res. Commun. 1999, 266, 633-640.
44. Rodriguez, F.; An, L. L.; Harkins, S.; Zhang, J.; Yokoyama, M.; Widera, G.; Fuller, J. T.; Kincaid, C.; Campbell, I. L.; Whitton, J. L. "DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination", J. Virol. 1998, 72, 5174-5181.
45. Sakamoto, K. M.; Kim, K. B.; Kumagai, A.; Mercurio, F.; Crews, C. M.; Deshaies, R. J. "Protacs: chimeric molecules that target proteins to the Skpl-Cullin-F box complex for ubiquitination and degradation", Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 8554-8559.
46. Whitehouse, A. S.; Khal, J.; Tisdale, M. J. "Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway", Br. J. Cancer 2003, 89, 737-745.
47. Gomes-Marcondes, M. C.; Tisdale, M. J. "Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress", Cancer Lett. 2002, 180, 69-74.
48. Castilleja, A.; Ward, N. E.; O'Brian, C. A.; Swearingen, B.; Swan, E.; Gillogly, M. A.; Murray, J. L.; Kudelka, A. P.; Gershenson, D. M.; Ioannides, C. G. "Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity", Mol. Cell. Biochem. 2001, 217, 21-33.